Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,985,848
+$398,221 QoQ
Shares Held
656,565
-6.5% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. DSGN ranks #160 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in DSGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,985,848 | 656,565 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,587,627 | 702,306 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,325,208 | 175,991 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $719,661 | 213,550 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $956,807 | 247,878 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,135,947 | 346,183 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,306,931 | 428,798 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,304,611 | 389,437 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,926,708 | 478,092 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,440,221 | 543,481 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $850,207 | 360,258 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,201,836 | 190,768 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $400,301 | 69,377 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $425,007 | 41,424 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $985,390 | 58,935 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $543,648 | 38,832 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $206,977 | 12,816 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $284,837 | 13,304 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $108,763 | 7,404 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,868 | 647 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||